SCHEMBL31328693

SCHEMBL31328693

CC(C)(C)OC(=O)N1C2CCC1CN(c1nc(Cl)nc(OC[C@@]34CCCN3C[C@H](F)C4)n1)C2

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 19/20 0.40
▸ GPR119 Q8TDV5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31328546 1.00 KRAS (0.40) KRASGPR119
SCHEMBL31328675 1.00 KRAS (0.40) KRASGPR119
SCHEMBL29151485 1.00 KRAS (0.40) KRASGPR119
SCHEMBL31328620 0.90 KRAS (0.40) KRASGPR119
SCHEMBL31328703 0.90 KRAS (0.39) KRASGPR119
SCHEMBL31328506 0.90 KRAS (0.39) KRASGPR119
SCHEMBL31328569 0.90 KRAS (0.39) KRASGPR119
SCHEMBL31328727 0.88 GPR119 (0.40) KRASGPR119
SCHEMBL31328535 0.88 KRAS (0.39) KRASGPR119
SCHEMBL31328623 0.88 KRAS (0.39) KRASGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025040767-A1 2-(3,8-DIAZABICYCLO[3.2.1]OCTAN-3-YL)-1,3,5-TRIAZINE DERIVATIVES AS KRAS G12D INHIBITORS FOR THE TREATMENT OF CANCER SANOFI (FR) 2025-02-27 — — WO disclosed
Send feedback